FDA Approves Truqap for Certain Metastatic, Hormone Receptor-Positive Breast Cancers
moderators
Posts: 9,599
FDA Approves Truqap for Certain Metastatic, Hormone Receptor-Positive Breast Cancers
Nov 17, 2023
Truqap is a new targeted therapy option for metastatic, hormone receptor-positive breast cancer with specific genetic mutations that has stopped responding to other hormonal therapy medicines. Read more…
q
Tagged:
0
Categories
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your NEW profile.